While death rates for most cancers have decreased over the years, the overall survival rate for pancreatic cancer hasn't budged in four decades, a lamentable statistic due in part to the lack of diagnostic biomarkers or procedures capable of detecting the disease in an early, localized stage and leading to better treatment outcomes.